Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maryam Dastmalchi

Showing results (1-10 of 48) with videos related to

Pageof 5
Sort By:
Rheumatic Diseases Clinics of North America|January 1, 2003
Possible pathogenic mechanisms in inflammatory myopathiesIngrid E Lundberg, Maryam Dastmalchi
The Journal of Rheumatology|June 5, 2012
Progressive multifocal leukoencephalopathy in a patient with polymyositis: case report and literature reviewMaryam Dastmalchi, Judit Laki, Ingrid E Lundberg, et al.
Acta Ophthalmologica|July 18, 2008
Treatment of idiopathic sclerosing inflammation of the orbit (myositis) with infliximabSven Sahlin, Börje Lignell, Maria Williams, et al.
Frontiers in Immunology|May 23, 2022
Screening for Anti-HMGCR Antibodies in a Large Single Myositis Center Reveals Infrequent Exposure to Statins and Diversiform Presentation of the DiseasePiotr Szczesny, Simone Barsotti, Inger Nennesmo, et al.
Arthritis Care & Research|October 26, 2020
Factors Associated With Treatment Response in Patients With Idiopathic Inflammatory Myopathies: A Registry-Based StudyFabricio Espinosa-Ortega, Marie Holmqvist, Maryam Dastmalchi, et al.
Journal of Autoimmunity|August 10, 2006
Genetically determined imbalance between serum levels of tumour necrosis factor (TNF) and interleukin (IL)-10 is associated with anti-Jo-1 and anti-Ro52 autoantibodies in patients with poly- and dermatomyositisAdla B Hassan, Maryam Fathi, Maryam Dastmalchi, et al.
Advances in Health Sciences Education : Theory and Practice|June 10, 2011
Experiencing virtual patients in clinical learning: a phenomenological studySamuel Edelbring, Maryam Dastmalchi, Håkan Hult, et al.
Clinical Rheumatology|April 13, 2016
Heterogeneous clinical spectrum of interstitial lung disease in patients with anti-EJ anti-synthetase syndrome: a case seriesMargherita Giannini, Antonella Notarnicola, Maryam Dastmalchi, et al.
Arthritis and Rheumatism|May 29, 2007
Benefits of intensive resistance training in patients with chronic polymyositis or dermatomyositisHelene Alexanderson, Maryam Dastmalchi, Mona Esbjörnsson-Liljedahl, et al.
Rheumatology (Oxford, England)|January 29, 2019
Efficacy and safety of rituximab in anti-synthetase antibody positive and negative subjects with idiopathic inflammatory myopathy: a registry-based studyValérie Leclair, Angeles Shunashy Galindo-Feria, Maryam Dastmalchi, et al.
Pageof 5

Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
Rheumatic Diseases Clinics of North America|January 1, 2003
Possible pathogenic mechanisms in inflammatory myopathiesIngrid E Lundberg, Maryam Dastmalchi
The Journal of Rheumatology|June 5, 2012
Progressive multifocal leukoencephalopathy in a patient with polymyositis: case report and literature reviewMaryam Dastmalchi, Judit Laki, Ingrid E Lundberg, et al.
Acta Ophthalmologica|July 18, 2008
Treatment of idiopathic sclerosing inflammation of the orbit (myositis) with infliximabSven Sahlin, Börje Lignell, Maria Williams, et al.
Frontiers in Immunology|May 23, 2022
Screening for Anti-HMGCR Antibodies in a Large Single Myositis Center Reveals Infrequent Exposure to Statins and Diversiform Presentation of the DiseasePiotr Szczesny, Simone Barsotti, Inger Nennesmo, et al.
Arthritis Care & Research|October 26, 2020
Factors Associated With Treatment Response in Patients With Idiopathic Inflammatory Myopathies: A Registry-Based StudyFabricio Espinosa-Ortega, Marie Holmqvist, Maryam Dastmalchi, et al.
Journal of Autoimmunity|August 10, 2006
Genetically determined imbalance between serum levels of tumour necrosis factor (TNF) and interleukin (IL)-10 is associated with anti-Jo-1 and anti-Ro52 autoantibodies in patients with poly- and dermatomyositisAdla B Hassan, Maryam Fathi, Maryam Dastmalchi, et al.
Advances in Health Sciences Education : Theory and Practice|June 10, 2011
Experiencing virtual patients in clinical learning: a phenomenological studySamuel Edelbring, Maryam Dastmalchi, Håkan Hult, et al.
Clinical Rheumatology|April 13, 2016
Heterogeneous clinical spectrum of interstitial lung disease in patients with anti-EJ anti-synthetase syndrome: a case seriesMargherita Giannini, Antonella Notarnicola, Maryam Dastmalchi, et al.
Arthritis and Rheumatism|May 29, 2007
Benefits of intensive resistance training in patients with chronic polymyositis or dermatomyositisHelene Alexanderson, Maryam Dastmalchi, Mona Esbjörnsson-Liljedahl, et al.
Rheumatology (Oxford, England)|January 29, 2019
Efficacy and safety of rituximab in anti-synthetase antibody positive and negative subjects with idiopathic inflammatory myopathy: a registry-based studyValérie Leclair, Angeles Shunashy Galindo-Feria, Maryam Dastmalchi, et al.
Pageof 5